Academy Project funding for Professor Mauri Kostiainen
Professor Mauri Kostiainen receives Consortium Project funding from the Academy of Finland
The SEMMA consortium aims to develop technologies for capturing human proteins directly from cell lines for their structure determination. These methods will be used to study several targets involved in human protein homeostasis, a control mechanism in every living cell. These novel technologies are expected to be widely applicable in studying basic biomolecular mechanisms and disease and offer potential for commercialization. SEMMA is a consortium between Prof. Kostiainen, head of the Biohybrid Materials Research Group at Aalto University, and project PI Prof. Juha T. Huiskonen and Dr. Ville Paavilainen at the University of Helsinki.
Read more news
Your voice gives away valuable personal information, so how do you keep that data safe?
With speech technologies becoming increasingly common, researchers want to make sure we don’t give away more information than we mean to.
Aalto in 2025: Quantum leaps, creative breakthroughs and solutions for a better life
Growth, technology and industrial renewal; human-centred solutions; health and everyday wellbeing; and enjoyable daily life and thriving communities.
Research Council of Finland establishes a Center of Excellence in Quantum Materials
The Centre, called QMAT, creates new materials to power the quantum technology of coming decades.